The takeover gives Boston Scientific ownership of an FDA-approved endoscopic device that ablates gastrointestinal tissue using radiofrequency waves.

Medeon Biodesign, a Taiwanese maker of minimally invasive surgical devices, sold its large bore vascular closure system to Terumo for $20 million.

J&J’s Janssen is transferring a respiratory assay panel and some of the staff who worked on it to Biocartis.

Abbott is paying $25 million upfront and committing to up to $67 million in development milestones to add the device to its vascular disease pipeline.

The partners think advanced imaging and software can enable a streamlined, automated workflow suitable for use on a large scale.

Cota, a healthcare data analytics company, will use the funds to advance its Cota Nodal Address disease classification system.

Months after losing its hepatitis C collaboration with Janssen, Achillion is trying to cut costs.

Johnson & Johnson's unit Apsis acquired French robot-assisted surgery company Orthotaxy for an undisclosed price.